Potnis, K. C., Ito, S., Kunst, N., Richman, I., Winer, E. P., Goshua, G. (2025). Cost-effectiveness of ribociclib plus endocrine therapy in HR-positive, HER2-negative early breast cancer in the United States.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11049